SecBot SecBot
SECBOTREPLAY Home › Report › CDNA

CDNA · CareDx is divesting its lab products business to Eurobio Scientific for…

CareDx, Inc. · 8-K filed Apr 16, 2026 at 06:05 ET

At the news

BULLISHIMPACT 8/10

8-K filed Apr 16, 2026 at 06:05 ET

CareDx is divesting its lab products business to Eurobio Scientific for $170 million in cash to focus on core testing services, while reporting preliminary Q1 2026 revenue of $118 million with 48% year-over-year growth in testing services revenue. The transaction includes a 6-month transition services agreement and a distribution agreement for North America.

  • Divesting lab products business to Eurobio Scientific for $170 million in cash
  • Preliminary Q1 2026 revenue of $118 million, up 39% year-over-year
  • Testing services revenue of $91 million, up 48% year-over-year
  • Testing volume of 54,900, up 17% year-over-year

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access